— Know what they know.
Not Investment Advice

TNGNQ OTC

Tengion, Inc.
1W: +0.0% 1M: +0.0% 3M: -90.0% YTD: -90.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 46 · $402 mcap · 35M float · 0.716% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
-$17M +11.9% ▲
Capital Expenditures
$106K -120.8% ▼
5Y CAGR: -47.6%
Free Cash Flow
-$17M +11.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$14M +918.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2009FY2010FY2011FY2012FY2013
— Operating Activities —
Net Income-$30M-$26M-$19M-$17M-$19M
Depreciation & Amort.$5M$5M$3M$456K$267K
Stock-Based Comp.$855K$954K$834K$566K$513K
Change in Working Capital-$724K$233K-$2M-$3M-$855K
Other Non-Cash Items-$1M$138K$2M$2M$7M
Operating Cash Flow-$26M-$19M-$22M-$19M-$17M
— Investing Activities —
Capital Expenditures-$289K-$152K-$81K-$48K-$106K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$17M-$33M-$13M$0$0
Investment Sales$20M$36M$7M$6M$0
Other Investing$7K$0$0-$1M$1M
Investing Cash Flow$2M$2M-$6M$5M$894K
— Financing Activities —
Net Debt Issuance-$5M-$14M-$4M$0$15M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$7K$144$0$13M$15M
Financing Cash Flow-$5M$12M$25M$13M$30M
Net Change in Cash-$29M-$5M-$3M-$2M$14M
Cash End of Period$17M$12M$9M$8M$22M
Free Cash Flow-$26M-$20M-$22M-$20M-$17M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms